3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
9
Gynecologic
5
Gastrointestinal
4
Genitourinary
3
Other hematologic neoplasm
2
Head & Neck
2
Classical hematology
2
Lymphoid
1
Conditions
Anemia, Refractory, with Excess of Blasts
168
Myelodysplastic Syndromes
160
Leukemia
156
Anemia
151
Leukemia, Myeloid, Acute
144
Neoplasms
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Leukemia, Myelomonocytic, Chronic
111
Multiple Myeloma
90
Myeloproliferative Disorders
89
Leukemia, Lymphocytic, Chronic, B-Cell
87
Lymphoma, Non-Hodgkin
76
Hodgkin Disease
71
Lymphoma
66
Congenital Abnormalities
64
Anemia, Refractory
64
Venous Thromboembolism
63
Thrombocytopenia
59
Blast Crisis
57
Leukemia, Myeloid, Chronic-Phase
56
Leukemia, Myeloid, Accelerated Phase
52
Lymphoma, Follicular
51
Myelodysplastic-Myeloproliferative Diseases
48
Anemia, Aplastic
46
Primary Myelofibrosis
44
Lymphoma, Mantle-Cell
44
Neoplasms, Plasma Cell
43
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
41
Burkitt Lymphoma
41
Interventions
Cognitive Behavioral Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Genetic Predisposition to Disease
×
Classical hematology
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled
NCT01346761
2016-04-14
REACH
University of Utah
Phase NA
Completed
1,012 enrolled